Artifact GuideEU

EU MDR vs IVDR What Changes

A practical comparison for mixed device portfolios.

Use this to decide which regulation applies, how classification differs, and what that means for evidence and operations.

Author
Sorena AI
Published
Feb 22, 2026
Updated
Feb 22, 2026
Sections
4

Structured answer sets in this page tree.

Primary sources
3

Cited legal and guidance references.

Publication metadata
Sorena AI
Published Feb 22, 2026
Updated Feb 22, 2026
Overview

MDR and IVDR share concepts (economic operators, conformity assessment, technical documentation, UDI/EUDAMED), but they diverge in scope and evidence expectations. If you build software and diagnostics workflows, the intended-purpose question becomes the single most important decision.

Section 1

Scope: when you're in MDR vs when you're in IVDR

MDR covers medical devices used on or in the human body (including many software functions) for prevention/diagnosis/monitoring/treatment-related intended purposes.

IVDR covers in vitro diagnostic medical devices: products intended to examine specimens derived from the human body to provide information about physiological/pathological states, congenital abnormalities, safety/compatibility with recipients, or to predict treatment responses.

  • If you analyze a specimen (blood, saliva, tissue) and output diagnostic information: treat IVDR as the default.
  • If you monitor or influence a patient directly (including software decision support): treat MDR as the default.
  • If your software supports both: split intended purposes and assess whether you have two regulated functions.
Recommended next step

Use EU MDR vs IVDR What Changes as a cited research workflow

Research Copilot can take EU MDR vs IVDR What Changes from how this topic compares with adjacent regulations or standards to a reusable workflow inside Sorena. Teams working on EU MDR vs IVDR can keep owners, evidence, and next steps aligned without copying this guide into separate documents.

Section 2

Classification: different systems, different consequences

MDR classification uses Annex VIII rules (Classes I, IIa, IIb, III). IVDR uses a separate classification approach (Classes A, B, C, D) driven by diagnostic impact and public health risk.

Operational impact: classification determines the conformity assessment route and the depth of evidence expected.

  • MDR: use an Annex VIII classification memo (include Rule 11 for software).
  • IVDR: classification often increases notified body involvement compared to the old IVD Directive regime; plan capacity early.
  • If you ship both: build a shared classification memo template but keep rule citations regulation-specific.
Section 3

Evidence: clinical evaluation (MDR) vs performance evaluation (IVDR)

The evidence story differs: MDR focuses on clinical evaluation for safety and performance in patients/users; IVDR focuses on performance evaluation (scientific validity, analytical performance, clinical performance) tied to intended diagnostic use.

Practical rule: write your claims as testable endpoints and build traceability from claims, evidence, and conclusions.

  • MDR: clinical evaluation plan + CER; PMCF where needed; PMS/PSUR and vigilance operations.
  • IVDR: performance evaluation plan + report; robust analytical/clinical performance studies; PMS and vigilance adapted to diagnostic contexts.
  • Software in both: ensure outputs, decision context, and harm scenarios are explicit; treat model changes as change-controlled events.
Section 4

Shared operational topics (where teams can reuse systems)

You can often reuse the operating system even when evidence differs.

Build shared QMS primitives and adapt regulation-specific procedures where needed.

  • Economic operator role mapping, document control, supplier control, and change control can be shared.
  • UDI and EUDAMED: shared data governance and submission processes, even if device data differs.
  • PMS and vigilance: shared signal/CAPA workflows with regulation-specific reporting obligations.
  • Training and internal audits: shared cadence with regulation-specific checklists.
Primary sources

References and citations

Related guides

Explore more topics

Applicability Test | EU Medical Device Regulation (MDR) 2017/745 | Is it a Medical Device? Annex XVI? Software Rule 11?
A step-by-step MDR applicability test for Regulation (EU) 2017/745: confirm intended purpose, device definition and exclusions.
CER Template | EU Medical Device Regulation (MDR) 2017/745 | Clinical Evaluation Report Structure (Annex XIV)
A practical Clinical Evaluation Report (CER) template for MDR (Regulation (EU) 2017/745): a copy-ready CER structure aligned to Annex XIV.
Clinical Evaluation Overview | EU Medical Device Regulation (MDR) 2017/745 | CER, Clinical Evidence Strategy, PMCF
A practical MDR clinical evaluation overview: how to define clinical claims and intended purpose, plan the clinical evaluation (CEP).
Compliance Checklist | EU Medical Device Regulation (MDR) 2017/745 | Technical Documentation, Clinical Evaluation, PMS, UDI/EUDAMED
An MDR compliance checklist you can run per device family: scope + role, classification and conformity assessment route, QMS controls (incl.
Compliance Guide | EU Medical Device Regulation (MDR) 2017/745 | QMS, Technical Documentation, Clinical Evaluation, PMS, UDI/EUDAMED
A practical EU MDR compliance guide for Regulation (EU) 2017/745: how to build an MDR operating model from scope and classification to conformity assessment.
Deadlines and Compliance Calendar | EU Medical Device Regulation (MDR) 2017/745 | Transition, Legacy Devices, EUDAMED
A practical MDR deadlines and compliance calendar: MDR application timing, Regulation (EU) 2023/607 transition conditions.
Device Classification Guide | EU Medical Device Regulation (MDR) 2017/745 | Annex VIII + Software Rule 11
A practical MDR device classification guide for Annex VIII: how to write a classification memo, apply implementing rules, decide invasiveness and duration.
FAQ | EU Medical Device Regulation (MDR) 2017/745 | Scope, Classification, Technical File, Clinical Evaluation, UDI/EUDAMED
High-signal EU MDR FAQ: Is my product a medical device? Is my software in scope? What is Rule 11? Do I need a notified body? What goes in the technical file.
Penalties and Fines | EU Medical Device Regulation (MDR) 2017/745 | Enforcement Risk + How to Reduce Exposure
A practical MDR enforcement guide: how penalties work under EU MDR (sanctions set by Member States), common enforcement triggers (misleading claims.
PMS and Vigilance | EU Medical Device Regulation (MDR) 2017/745 | PMS Plan, PSUR, Serious Incidents, FSCA
A practical MDR PMS and vigilance guide: build the Annex III PMS system, decide when PSUR or PMS report applies, meet serious-incident timelines of 15 days.
PMS Plan Template | EU Medical Device Regulation (MDR) 2017/745 | Annex III-Aligned Outline + Metrics
A practical MDR Post-Market Surveillance (PMS) plan template aligned to MDR Annex III: copy-ready sections for device scope, data sources.
QMS and Technical File | EU Medical Device Regulation (MDR) 2017/745 | Annex II/III Technical Documentation + QMS Controls
A practical MDR QMS and technical-file guide: Article 10 and 15 governance, Annex II and III file structure, GSPR traceability.
Requirements | EU Medical Device Regulation (MDR) 2017/745 | Core Obligations + Evidence Outputs
A grounded MDR requirements guide for Regulation (EU) 2017/745: scope and role mapping, Annex VIII classification, Article 10 and 15 governance.
Transition Timelines | EU Medical Device Regulation (MDR) 2017/745 | Legacy Devices, 2023/607 Extension, Significant Changes
A practical MDR transition and legacy-device timeline guide: how Article 120 works after Regulation (EU) 2023/607, which conditions must stay true.
UDI and EUDAMED | EU Medical Device Regulation (MDR) 2017/745 | UDI-DI/PI, Basic UDI-DI, Actor Registration, Device Registration
A practical MDR UDI and EUDAMED guide: Basic UDI-DI, UDI-DI, UDI-PI, actor registration and SRN, Article 29 device registration.